2006
DOI: 10.1016/j.biomaterials.2006.02.016
|View full text |Cite
|
Sign up to set email alerts
|

Structural requirements for stabilization of vascular elastin by polyphenolic tannins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
76
0
3

Year Published

2009
2009
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(79 citation statements)
references
References 24 publications
0
76
0
3
Order By: Relevance
“…The phenolic nature of tannins which is embedded within its comparatively hydrophilic "shell" and hydrophobic "core" are the features responsible for its antioxidant action [30,31]. The properties of tannin-rich extracts was observed in meat model system studies on bearberry leaf (Arctostaphylos uva-ursi) extract and characterized by the existence of hydrolysable and condensed tannins [32].…”
Section: Tannic Acid (Tannins)mentioning
confidence: 99%
“…The phenolic nature of tannins which is embedded within its comparatively hydrophilic "shell" and hydrophobic "core" are the features responsible for its antioxidant action [30,31]. The properties of tannin-rich extracts was observed in meat model system studies on bearberry leaf (Arctostaphylos uva-ursi) extract and characterized by the existence of hydrolysable and condensed tannins [32].…”
Section: Tannic Acid (Tannins)mentioning
confidence: 99%
“…Similar to many other plant polyphenols, TA possesses anti-oxidant, anti-inflammatory, anti-microbial, antiproteolytic effects, anti-mutagenic effect 2 . It is known to form multiple hydrogen bonds with proteins, particularly those rich in proline such as elastin and collagen and used in the manufacture of gelatin product and leather adhesives 3,4 . It has been suggested as a potential crosslinking agent and improves the elastin and collagen stability in cardiovascular implants as evidenced by an increased resistance to proteolytic degradation against collagenase activity 5,6 .…”
Section: Introductionmentioning
confidence: 99%
“…9 Despite their relative merits and demerits, long-term cardiac=pulmonary complications and other surgical and graft-associated complications cause survival rates to drop drastically within 10 years postsurgery. 10 Other prominent nonsurgical approaches to inhibit inflammation and elastin matrix degradation within aneurysmals include pharmacologically inhibiting release and activity of proteolytic matrix metalloproteinases (MMPs) 11 by tissue inhibitors of matrix metalloproteases (TIMP), or other drugs, 12 chemically stabilizing existing matrix structures, 13,14 and repairing already-developed aneurysms by endovascularly seeded healthy cells. 15 Unfortunately, none of these strategies present an integrated approach to modulate aneurysmal cell phenotype, reinstate healthy matrix architecture, and provide conditions for stabilizing the local vascular environment.…”
Section: Introductionmentioning
confidence: 99%